Department of Clinical Genetics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Professor Lu Neurological Clinic, Taoyuan, Taiwan.
Ann Neurol. 2021 Mar;89(3):485-497. doi: 10.1002/ana.25973. Epub 2020 Dec 15.
The study was undertaken to identify a monogenic cause of early onset, generalized dystonia.
Methods consisted of genome-wide linkage analysis, exome and Sanger sequencing, clinical neurological examination, brain magnetic resonance imaging, and protein expression studies in skin fibroblasts from patients.
We identified a heterozygous variant, c.388G>A, p.Gly130Arg, in the eukaryotic translation initiation factor 2 alpha kinase 2 (EIF2AK2) gene, segregating with early onset isolated generalized dystonia in 5 patients of a Taiwanese family. EIF2AK2 sequencing in 191 unrelated patients with unexplained dystonia yielded 2 unrelated Caucasian patients with an identical heterozygous c.388G>A, p.Gly130Arg variant, occurring de novo in one case, another patient carrying a different heterozygous variant, c.413G>C, p.Gly138Ala, and one last patient, born from consanguineous parents, carrying a third, homozygous variant c.95A>C, p.Asn32Thr. These 3 missense variants are absent from gnomAD, and are located in functional domains of the encoded protein. In 3 patients, additional neurological manifestations were present, including intellectual disability and spasticity. EIF2AK2 encodes a kinase (protein kinase R [PKR]) that phosphorylates eukaryotic translation initiation factor 2 alpha (eIF2α), which orchestrates the cellular stress response. Our expression studies showed abnormally enhanced activation of the cellular stress response, monitored by PKR-mediated phosphorylation of eIF2α, in fibroblasts from patients with EIF2AK2 variants. Intriguingly, PKR can also be regulated by PRKRA (protein interferon-inducible double-stranded RNA-dependent protein kinase activator A), the product of another gene causing monogenic dystonia.
We identified EIF2AK2 variants implicated in early onset generalized dystonia, which can be dominantly or recessively inherited, or occur de novo. Our findings provide direct evidence for a key role of a dysfunctional eIF2α pathway in the pathogenesis of dystonia. ANN NEUROL 2021;89:485-497.
本研究旨在确定早发性、全身性肌张力障碍的单基因病因。
方法包括全基因组连锁分析、外显子和 Sanger 测序、患者皮肤成纤维细胞的临床神经检查、脑磁共振成像和蛋白表达研究。
我们在一个台湾家庭的 5 名早发性孤立性全身性肌张力障碍患者中发现了真核翻译起始因子 2α 激酶 2(EIF2AK2)基因的杂合变异 c.388G>A,p.Gly130Arg。EIF2AK2 测序在 191 名不明原因的肌张力障碍患者中发现了 2 名无关的白种人患者,他们携带相同的杂合 c.388G>A,p.Gly130Arg 变异,其中 1 例为新生突变,另 1 例患者携带不同的杂合变异 c.413G>C,p.Gly138Ala,最后 1 例患者出生于近亲结婚的父母,携带第三种纯合变异 c.95A>C,p.Asn32Thr。这些 3 种错义变异在 gnomAD 中不存在,并且位于编码蛋白的功能域中。在 3 名患者中,还存在其他神经表现,包括智力障碍和痉挛。EIF2AK2 编码一种激酶(蛋白激酶 R [PKR]),可磷酸化真核翻译起始因子 2α(eIF2α),从而协调细胞应激反应。我们的表达研究表明,在 EIF2AK2 变异患者的成纤维细胞中,细胞应激反应异常增强,通过 PKR 介导的 eIF2α磷酸化来监测。有趣的是,PKR 也可以被另一个引起单基因肌张力障碍的基因 PRKRA(双链 RNA 依赖性蛋白激酶激活剂 A 的干扰素诱导蛋白)调节。
我们发现 EIF2AK2 变异与早发性全身性肌张力障碍有关,这些变异可以是显性或隐性遗传,也可以是新生突变。我们的研究结果提供了直接证据,证明功能失调的 eIF2α 途径在肌张力障碍的发病机制中起关键作用。ANN NEUROL 2021;89:485-497。